Articles published by Elucid

Elucid Announces FDA Clearance of FFR-IQ™ and Commercial Availability of the Most Accurate¹ FFR-CT Software

Today 7:05 EDT

From Elucid

Via Business Wire

Elucid Appoints Mark Miller as Chief Revenue Officer to Lead Commercial Expansion Ahead of BioIntegrated FFR-CT Launch

September 29, 2026

From Elucid

Via Business Wire

Elucid Raises $55 Million in Oversubscribed Series D Financing

September 02, 2026

From Elucid

Via Business Wire

Elucid Announces First Patient Enrollment in AI-PREDICT, a Landmark International Study to Define Lesion-Level Cardiovascular Risk

July 09, 2026

From Elucid

Via Business Wire

Elucid to Showcase CCTA Vision at SCCT 2026, Defining the Future of Personalized Cardiovascular Care

July 06, 2026

From Elucid

Via Business Wire

Elucid’s Plaque-IQ™ Named “Best New Cardiology Technology Solution” in 2026 MedTech Breakthrough Awards Program

May 07, 2026

From Elucid

Via Business Wire

Elucid Announces Commercial Availability of Lesion Inspection Tool for Plaque-IQ™

April 15, 2026

From Elucid

Via Business Wire

Elucid Announces Broad Reimbursement for Quantitative Coronary Plaque Analysis

January 09, 2026

From Elucid

Via Business Wire

Elucid Gains Broad CMS Reimbursement of Coronary Plaque Analysis Using PlaqueIQ™

December 03, 2025

From Elucid

Via Business Wire

Elucid Launches PlaqueIQ Image Analysis Software for the Carotid Arteries

October 29, 2025

From Elucid

Via Business Wire

Elucid’s PlaqueIQ™ Image Analysis Software Now Covered by United Healthcare

August 11, 2025

From Elucid

Via Business Wire

Elucid Names Richard E. Kuntz, MD, MSc and Shamiram Feinglass, MD, MPH Board Directors

July 17, 2025

From Elucid

Via Business Wire

Elucid Applauds CMS Inclusion of Coronary CTA with Plaque Analysis in 2026 Proposed Medicare Physician Fee Schedule

July 15, 2025

From Elucid

Via Business Wire

Elucid’s PlaqueIQ™ Image Analysis Software Included in EviCore Coverage Guidelines

July 14, 2025

From Elucid

Via Business Wire

Elucid to Showcase PlaqueIQ™ at SCCT 2025

July 10, 2025

From Elucid

Via Business Wire

Elucid Appoints Dr. Robert Pelberg as New Senior Vice President of Medical Affairs

July 07, 2025

From Elucid

Via Business Wire

Elucid Adds Clinical and Commercial Leadership Ahead of PlaqueIQ™ Launch

March 03, 2025

From Elucid

Via Business Wire

Elucid Announces Fifth Medicare Administrative Contractor to Cover AI Coronary Plaque Analysis

October 25, 2024

From Elucid

Via Business Wire

Elucid Announces Favorable Medicare Coverage of AI Coronary Plaque Analysis

October 15, 2024

From Elucid

Via Business Wire

Elucid Receives U.S. 510(k) Clearance of PlaqueIQ™ Image Analysis Software to Aid Cardiovascular Disease Assessment

October 01, 2024

From Elucid

Via Business Wire

Elucid Names Kelly Huang as CEO

July 22, 2024

From Elucid

Via Business Wire

Elucid Commences International PRE-VUE CCT Registry Study

July 18, 2024

From Elucid

Via Business Wire

Elucid Moves into New Headquarters in Preparation for Commercial Launch

June 27, 2024

From Elucid

Via Business Wire

Elucid Raises $80 Million in Series C Round Led by Elevage Medical Technologies

November 09, 2023

From Elucid

Via Business Wire

Elucid Announces American Medical Association (AMA) Instates CPT Code for Lipid-Rich Necrotic Core Quantification to Assess Atherosclerotic Plaque Stability

December 20, 2021

From Elucid

Via Business Wire

Elucid Eyes Big Opportunity to Save Lives with Software Amidst Major Guideline Changes

October 29, 2021

From Elucid

Via Business Wire

Elucid Presents Data Demonstrating Its AI Software Can Uniquely Quantify Key Drivers of Heart Attack and Stroke from Computed Tomography

July 16, 2021

From Elucid

Via Business Wire

Elucid Secures $8 Million in Series A Funding Led by MedTex Ventures and Global Health Impact Fund

May 10, 2021

From Elucid

Via Business Wire

Elucid Presents Results of the EVAPORATE Study at ESC Preventive Cardiology 2021 Late Breakers

April 17, 2021

From Elucid

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.